Top Page
Chrysos Corp. Ltd.
(Sydney:C79)
Chrysos Corp. Ltd. (C79) vs. iShares MSCI Australia ETF (EWA)
Chrysos Corp. Ltd. Business Overview & Revenue Model
Chrysos Corp. Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.20M | 66.11M | 45.36M | 26.82M | 571.00K | 47.00K |
| Gross Profit | -6.32M | 66.09M | 34.42M | 25.73M | 29.00K | -6.78M |
| EBITDA | 16.41M | 17.34M | 11.68M | 5.09M | 2.16M | -1.03M |
| Net Income | -8.22M | -8.22M | -704.00K | 443.00K | -3.94M | -3.84M |
Balance Sheet | ||||||
| Total Assets | 264.31M | 264.31M | 243.26M | 163.41M | 144.09M | 29.51M |
| Cash, Cash Equivalents and Short-Term Investments | 21.52M | 21.52M | 61.07M | 53.36M | 92.10M | 5.77M |
| Total Debt | 25.41M | 25.41M | 6.67M | 14.28M | 8.82M | 3.14M |
| Total Liabilities | 66.01M | 66.01M | 44.99M | 39.18M | 21.77M | 15.28M |
| Stockholders Equity | 198.30M | 198.30M | 198.27M | 124.23M | 122.32M | 14.23M |
Cash Flow | ||||||
| Free Cash Flow | -59.21M | -59.89M | -56.23M | -42.61M | -25.67M | -7.46M |
| Operating Cash Flow | 6.95M | 8.83M | 3.63M | 4.65M | 1.41M | 613.00K |
| Investing Cash Flow | -68.72M | -68.72M | -59.86M | -47.26M | -26.98M | -8.07M |
| Financing Cash Flow | 19.16M | 17.28M | 64.30M | 3.54M | 111.52M | -268.00K |
Chrysos Corp. Ltd. Technical Analysis
Chrysos Corp. Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$641.42M | 38.09 | 12.02% | 4.18% | 4.03% | 31.66% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | AU$550.95M | 92.40 | 10.18% | 0.43% | 17.12% | 311.38% | |
55 Neutral | AU$1.10B | 387.50 | <0.01% | ― | -29.99% | -66.84% | |
48 Neutral | AU$879.40M | -106.31 | -4.15% | ― | -89.69% | -658.51% | |
43 Neutral | AU$637.52M | -67.32 | -3.19% | ― | 0.40% | -280.65% | |
39 Underperform | AU$172.33M | -11.73 | -89.84% | ― | 127.89% | -107.34% |
Chrysos Corp. Ltd. Corporate Events
Chrysos Corporation Limited announced the cessation of 6,653 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.
Chrysos Corporation Limited announced a change in the director’s interest, with Gregory Vincent Holt acquiring an additional 10,450 fully paid ordinary shares through the GVH Trust. This acquisition increases the total shares held by the trust to 22,450, reflecting a strategic move that may signal confidence in the company’s future prospects and could impact stakeholder perceptions positively.
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) has sold approximately 10.75 million shares in Chrysos Corporation, reducing its stake by half but retaining a significant 9% interest. This move reflects CSIRO’s ongoing support for Chrysos, which has grown into a leading provider of assay solutions in the mining industry since its spin-out in 2016. The sale introduces new investors to Chrysos, positioning the company for its next growth phase.
Chrysos Corporation announced that all resolutions from its 2025 Annual General Meeting were passed by a requisite majority through a poll. This includes the adoption of the remuneration report, election and re-election of directors, approval of the FY26 CEO LTI Award, and potential termination benefits for key executives. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued strategic growth and leadership in the mining technology sector.
Chrysos Corporation Limited has presented its latest advancements in gold analysis technology, emphasizing improvements in speed and accuracy. This development is expected to enhance the company’s operational efficiency and strengthen its position in the mining technology sector, offering significant benefits to stakeholders involved in gold mining and analysis.
Chrysos Corporation has reported a successful fiscal year 2025, marked by significant financial growth and operational achievements. The company experienced a 46% increase in revenue and an 80% rise in EBITDA, driven by the growing demand for its PhotonAssay™ technology. This innovative solution offers a competitive edge by providing more accurate gold analysis compared to traditional methods, which has led to its widespread adoption. Chrysos expanded its global footprint by entering the South American market and strengthened partnerships with major mining companies. The company also emphasized its commitment to sustainability, with PhotonAssay™ technology significantly reducing energy usage and emissions. Looking ahead, Chrysos plans to accelerate its global expansion and continue fostering customer relationships to sustain its growth trajectory.
Chrysos Corporation has reported a strong operational performance in FY25, expanding its global reach and advancing its PhotonAssay technology. The company has established itself as a trusted partner in the gold mining industry, with significant growth in South America through a partnership with Bureau Veritas. The start of FY26 shows promising momentum with increased sample volumes and new contracts, contributing to a positive revenue outlook. Chrysos aims to continue expanding its deployments, enhancing operational efficiency, and advancing its technology to maintain its leadership in assay innovation.
Chrysos Corporation Limited announced the cessation of 3,436 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
Chrysos Corporation Limited has announced its 2025 Annual General Meeting, scheduled for November 24, 2025, at its headquarters in Adelaide, South Australia. The meeting will address important shareholder voting matters, with eligibility determined by shareholding status as of November 22, 2025. Shareholders are encouraged to vote by proxy if unable to attend in person, with specific instructions provided for submitting proxy forms. The Chair plans to vote in favor of the resolutions outlined in the meeting agenda.
Chrysos Corporation Limited has announced the issuance of 12,500 ordinary fully paid securities, which are set to be quoted on the Australian Securities Exchange (ASX) under the code C79. This move is part of the company’s strategic efforts to enhance its capital structure and potentially strengthen its market position, offering stakeholders an opportunity to invest in its growth trajectory.
Chrysos Corporation Limited has announced the appointment of Elisha Joyce Civil as a new director, effective from October 15, 2025. This update is part of the company’s compliance with ASX listing rules, specifically regarding the disclosure of directors’ interests in securities. The announcement does not indicate any current interests in securities or contracts held by the new director, suggesting a straightforward integration into the company’s governance structure without immediate financial implications for stakeholders.
Chrysos Corporation Limited has announced the quotation of 17,500 ordinary fully paid securities on the Australian Securities Exchange (ASX), with the issue date of October 13, 2025. This move is part of the company’s strategic efforts to strengthen its financial position and enhance its market presence, potentially impacting its operational capabilities and offering growth opportunities for stakeholders.
Chrysos Corporation has appointed Elisha Civil as an independent Non-Executive Director, effective October 15, 2025. With over 20 years of experience in financial governance and strategic transformation across the mining, energy, and infrastructure sectors, Ms. Civil’s appointment is expected to enhance the company’s governance and support its global expansion efforts. Her expertise in capital markets and business transformation aligns with Chrysos’s commitment to growth and innovation, particularly in the deployment of its PhotonAssay technology.
Chrysos Corporation Limited announced a change in the director’s interest notice, specifically for Director Robert Henry Richard Adamson. The change involves the disposal of 250,000 fully paid ordinary shares at an average price of $7.7577 per share, reducing his holdings as a registered holder to 809,914 shares. This transaction was conducted as an on-market trade and reflects a strategic adjustment in the director’s investment portfolio within the company.
Chrysos Corporation Limited announced the cessation of 8,575 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.
Chrysos Corporation has announced key dates for its 2025 calendar, including the closing date for director nominations on October 7 and its Annual General Meeting on November 24. This announcement highlights the company’s ongoing commitment to transparency and governance, potentially impacting its operations and stakeholder engagement.
Chrysos Corporation Limited has announced the issuance of 67,500 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code C79. This move is part of the company’s strategy to enhance its financial flexibility and strengthen its market position, potentially impacting stakeholders by increasing the company’s capital base and supporting its growth initiatives.
Chrysos Corporation Limited announced a change in the director’s interest, with Dirk Moore Treasure disposing of 200,000 fully paid ordinary shares and exercising 27,500 options to acquire the same number of shares. This transaction reflects a strategic adjustment in the director’s holdings, potentially impacting the company’s stock market performance and signaling confidence in its future prospects.
Chrysos Corporation Limited has announced the issuance of 62,500 fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX) under the code C79. This move is part of the company’s strategy to leverage convertible securities and options, potentially enhancing its market presence and providing additional capital for growth and development initiatives.
Chrysos Corporation Limited has announced the quotation of 5,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code C79, effective from September 3, 2025. This move is part of the company’s strategy to leverage financial markets for growth and expansion, potentially impacting its market positioning and offering stakeholders an opportunity to engage with its financial developments.